Cover Image
市場調查報告書

避孕器的全球市場 (2015∼2019年)

Global Contraceptive Devices Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 335545
出版日期 內容資訊 英文 91 Pages
訂單完成後即時交付
價格
Back to Top
避孕器的全球市場 (2015∼2019年) Global Contraceptive Devices Market 2015-2019
出版日期: 2015年07月15日 內容資訊: 英文 91 Pages
簡介

避孕手段分為一時性和永久性,男性用、女性用雙方皆是。永久性手段中,有女性方面的節育手術 (輸卵管閉塞、子宮鏡檢查等) 和男性方面的節育手術 (輸精管切除等)。一時性避孕手段有荷爾蒙系、非荷爾蒙系統2種,荷爾蒙系的避孕手段為避孕用經皮吸收貼片和口服避孕藥丸,荷爾蒙系IUD (子宮內避孕器),避孕環,陰道內植入等,還有非荷爾蒙系有,子宮托、保險套、海綿、子宮頸部保護蓋 (膈膜避孕法)、有非荷爾蒙系IUD等。全球避孕器市場2014∼2019年,預計以4.88%的年複合成長率(CAGR) 成長。

本報告提供全球的避孕用器具的市場相關分析,市場概要和結構,市場規模趨勢 (今後5年的預測值),各產品、各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查評估。

第1章 摘要整理

第2章 簡稱集

第3章 分析範圍

  • 市場概要
  • 主要的產品

第4章 市場分析技術

  • 市場分析的流程
  • 分析方法

第5章 簡介

第6章 避孕手段的種類

第7章 市場環境

  • 市場概況
  • 市場規模與其預測
  • 波特的五力分析

第8章 各產品種類的市場區隔

第9章 全球保險套市場

  • 市場規模與其預測

第10章 全球IUD (子宮內避孕器) 市場

第11章 全球皮下置入式避孕器市場

第12章 全球避孕環市場

第13章 全球非外科的、永久的避孕器市場

第14章 全球避孕用隔膜 (子宮托) 市場

第15章 全球避孕用海綿市場

第16章 地區區分

  • 南北美洲市場
  • 歐洲、中東、非洲地區 (EMEA) 市場
  • 亞太地區市場

第17章 購買標準

第18章 促進市場成長的要素

第19章 推動因素與其影響力

第20章 市場課題

第21章 推動因素、課題的影響力

第22章 市場趨勢

第23章 市場趨勢與其影響

第24章 供應商環境

  • 競爭方案
    • 近幾年的主要趨勢
    • 企業合併、收購 (M&A)
  • 市場佔有率分析
  • 其他卓越供應商

第25章 主要供應商分析

  • Actavis
    • 主要資料
    • 產業概要
    • 各部門的市場收益額
    • 各部門的市場收益額 (與上年度的比較)
    • 各地區的市場收益額 (最新值)
    • 產業策略
    • 最近的發展趨勢
    • SWOT分析
  • Ansell
  • Bayer
  • Church & Dwight
  • Merck

第26章 相關報告

圖表一覽

目錄
Product Code: IRTNTR6472

About Contraception Devices

Contraception methods can be temporary or permanent and are available for both men and women. Permanent methods include sterilization for women (tubal occlusion or hysteroscopy) and sterilization for men (vasectomy). Temporary methods are hormonal and non-hormonal. Hormonal methods include contraceptive transdermal patches, oral contraceptive pills, hormonal IUDs, vaginal rings, and vaginal implants. Non-hormonal methods include withdrawal methods, diaphragms, condoms, sponges, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods.

Technavio's analysts forecast the global contraceptive devices market to grow at a CAGR of 4.88% over the period 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the global contraceptive devices market for the period 2015-2019. To calculate the market size, we considered revenue generated from sales of various contraception devices.

Technavio's report, Global Contraceptive Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global contraceptive devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Ansell
  • Actavis
  • Bayer
  • Church & Dwight
  • Merck & Co
  • Other Prominent Vendor
  • Agile Therapeutics
  • Caya
  • Condomi Health International
  • Fuji Latex
  • HLL Lifecare
  • Karex Industries
  • Lipocine
  • Mayer Laboratories
  • Medicines 360
  • Okamoto Industries
  • Reckitt Benckiser Group
  • Teva Pharmaceuticals
  • The Female Health Company
  • TodaySponge

Market Driver

  • Growing Prevalence of Unplanned Pregnancies
  • For a full, detailed list, view our report

Market Challenge

  • Threat of Low-Cost Generic Contraceptives
  • For a full, detailed list, view our report

Market Trend

  • Increasing Strategic Partnerships
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Types of Contraceptive Methods

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Product Type

09. Global Condoms Market

  • 09.1. Market Size and Forecast

10. Global IUDs Market

  • 10.1. Market Size and Forecast

11. Global Subdermal Contraceptive Implants Market

  • 11.1. Market Size and Forecast

12. Global Vaginal Rings Market

  • 12.1. Market Size and Forecast

13. Global Non-surgical Permanent Contraception Devices Market

  • 13.1. Market Size and Forecast

14. Global Contraceptive Diaphragms Market

  • 14.1. Market Size and Forecast

15. Global Contraceptive Sponges Market

  • 15.1. Market Size and Forecast

16. Geographical Segmentation

  • 16.1. Contraceptive Devices Market in Americas
    • 16.1.1. Market Size and Forecast
  • 16.2. Contraceptive Devices Market in EMEA
    • 16.2.1. Market Size and Forecast
  • 16.3. Contraceptive Devices Market in APAC
    • 16.3.1. Market Size and Forecast

17. Buying Criteria

18. Market Growth Drivers

19. Drivers and Their Impact

20. Market Challenges

21. Impact of Drivers and Challenges

22. Market Trends

23. Trends and Their Impact

24. Vendor Landscape

  • 24.1. Competitive Scenario
    • 24.1.1. Key News
    • 24.1.2. Mergers and Acquisitions
  • 24.2. Market Share Analysis 2014
    • 24.2.1. Actavis
    • 24.2.2. Ansell
    • 24.2.3. Bayer
    • 24.2.4. Church & Dwight
    • 24.2.5. Merck
  • 24.3. Other Prominent Vendors

25. Key Vendor Analysis

  • 25.1. Actavis
    • 25.1.1. Key Facts
    • 25.1.2. Business Overview
    • 25.1.3. Business Segmentation
    • 25.1.4. Business Segmentation by Revenue 2012 and 2013
    • 25.1.5. Geographical Segmentation by Sales 2013
    • 25.1.6. Business Strategy
    • 25.1.7. Recent Developments
    • 25.1.8. SWOT Analysis
  • 25.2. Ansell
    • 25.2.1. Key Facts
    • 25.2.2. Business Overview
    • 25.2.3. Business Segmentation by Revenue 2014
    • 25.2.4. Business Segmentation by Revenue 2013 and 2014
    • 25.2.5. Geographical Segmentation by Revenue 2014
    • 25.2.6. Recent Developments
    • 25.2.7. SWOT Analysis
  • 25.3. Bayer
    • 25.3.1. Key Facts
    • 25.3.2. Business Overview
    • 25.3.3. Business Segmentation by Revenue 2014
    • 25.3.4. Business Segmentation by Revenue 2013 and 2014
    • 25.3.5. Geographical Segmentation by Revenue 2014
    • 25.3.6. Business Strategy
    • 25.3.7. Recent Developments
    • 25.3.8. SWOT Analysis
  • 25.4. Church & Dwight
    • 25.4.1. Key Facts
    • 25.4.2. Business Overview
    • 25.4.3. Business Segmentation by Revenue 2013
    • 25.4.4. Business Segmentation by Revenue 2012 and 2013
    • 25.4.5. Geographical Segmentation by Revenue 2013
    • 25.4.6. Business Strategy
    • 25.4.7. Recent Developments
    • 25.4.8. SWOT Analysis
  • 25.5. Merck
    • 25.5.1. Key Facts
    • 25.5.2. Business Overview
    • 25.5.3. Business Segmentation by Revenue 2013
    • 25.5.4. Business Segmentation by Revenue 2012 and 2013
    • 25.5.5. Sales by Geography
    • 25.5.6. Business Strategy
    • 25.5.7. Key Developments
    • 25.5.8. SWOT Analysis

26. Other Reports in This Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Market Overview
  • Exhibit 3: Global Contraceptive Devices Market 2014-2019 ($ millions)
  • Exhibit 4: Segmentation of Global Contraceptive Devices Market by Product Type
  • Exhibit 5: Segmentation of Global Contraceptive Devices Market by Product Type 2014
  • Exhibit 6: Global Condoms Market 2014-2019 ($ millions)
  • Exhibit 7: Global IUDs Market 2014-2019 ($ millions)
  • Exhibit 8: Global Subdermal Contraceptive Implants Market 2014-2019 ($ millions)
  • Exhibit 9: Global Vaginal Rings Market 2014-2019 ($ millions)
  • Exhibit 10: Global Non-surgical Permanent Contraception Devices Market 2014-2019 ($ millions)
  • Exhibit 11: Global Contraceptive Diaphragms Market 2014-2019 ($ millions)
  • Exhibit 12: Global Contraceptive Sponges Market 2014-2019 ($ millions)
  • Exhibit 13: Segmentation of Global Contraceptive Devices Market by Product Type 2014-2019 ($ millions)
  • Exhibit 14: Segmentation of Global Contraceptive Devices Market by Product Type 2014-2019
  • Exhibit 15: Segmentation of Global Contraceptive Devices Market by Geography 2014
  • Exhibit 16: Contraceptive Devices Market in Americas 2014-2019 ($ millions)
  • Exhibit 17: Contraceptive Devices Market in EMEA 2014-2019 ($ millions)
  • Exhibit 18: Contraceptive Devices Market in APAC 2014-2019 ($ millions)
  • Exhibit 19: Segmentation of Global Contraceptive Devices Market by Geography 2014-2019 ($ millions)
  • Exhibit 20: Segmentation of Global Contraceptive Devices Market by Geography 2014-2019
  • Exhibit 21: Major Drivers of Global Contraceptive Devices Market
  • Exhibit 22: STDs in US
  • Exhibit 23: Estimated Cases of STIs in US
  • Exhibit 24: Total Population Growth Rate and Crude Birthrate 2007-2012
  • Exhibit 25: Major Challenges in Global Contraceptive Devices Market
  • Exhibit 26: Major Trends in Global Contraceptive Devices Market
  • Exhibit 27: Global Fertility Rate 2007-2012
  • Exhibit 28: Actavis: Key Takeaways
  • Exhibit 29: Ansell: Key Takeaways
  • Exhibit 30: Bayer: Key Takeaways
  • Exhibit 31: Church & Dwight: Key Takeaways
  • Exhibit 32: Merck: Key Takeaways
  • Exhibit 33: Actavis: Business Segmentation
  • Exhibit 34: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 35: Actavis: Geographical Segmentation by Sales 2013
  • Exhibit 36: Ansell: Business Segmentation by Revenue 2014
  • Exhibit 37: Ansell: Business Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 38: Ansell: Geographical Segmentation by Revenue 2014
  • Exhibit 39: Bayer: Business Segmentation by Revenue 2014
  • Exhibit 40: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
  • Exhibit 41: Bayer: Geographical Segmentation by Revenue 2014
  • Exhibit 42: Church & Dwight: Business Segmentation by Revenue 2013
  • Exhibit 43: Church & Dwight: Business Segmentation by Revenue 2012 and 2013 ($ billions)
  • Exhibit 44: Church & Dwight: Geographical Segmentation by Revenue 2013
  • Exhibit 45: Merck: Business Segmentation by Revenue 2013
  • Exhibit 46: Merck: Business Segmentation by Revenue 2012 and 2013 ($ billions)
  • Exhibit 47: Merck: Sales by Geography 2013
Back to Top